160 related articles for article (PubMed ID: 33104883)
21. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Ewing's sarcoma using an antisense oligodeoxynucleotide to regulate the cell cycle.
Asami S; Chin M; Shichino H; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
Biol Pharm Bull; 2008 Mar; 31(3):391-4. PubMed ID: 18310898
[TBL] [Abstract][Full Text] [Related]
23. Ewing's sarcoma of the cervix: A case report and review of literature.
Zhang Y; Nong W; Ren Y; Jiang J; Zhang H; Meng L; Li Q; Zhang Q; Wang X; Wang Y; Liu C; Li F
Histol Histopathol; 2020 May; 35(5):475-480. PubMed ID: 31688946
[TBL] [Abstract][Full Text] [Related]
24. Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma.
Boro A; Prêtre K; Rechfeld F; Thalhammer V; Oesch S; Wachtel M; Schäfer BW; Niggli FK
Int J Cancer; 2012 Nov; 131(9):2153-64. PubMed ID: 22323082
[TBL] [Abstract][Full Text] [Related]
25. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
Ginsberg JP; de Alava E; Ladanyi M; Wexler LH; Kovar H; Paulussen M; Zoubek A; Dockhorn-Dworniczak B; Juergens H; Wunder JS; Andrulis IL; Malik R; Sorensen PH; Womer RB; Barr FG
J Clin Oncol; 1999 Jun; 17(6):1809-14. PubMed ID: 10561219
[TBL] [Abstract][Full Text] [Related]
26. Effects of baicalein on proliferation, apoptosis, migration and invasion of Ewing's sarcoma cells.
Ye C; Yu X; Zeng J; Dai M; Zhang B
Int J Oncol; 2017 Dec; 51(6):1785-1792. PubMed ID: 29039470
[TBL] [Abstract][Full Text] [Related]
27. Combined analysis of gene expression and genome binding profiles identified potential therapeutic targets of ciclopirox in Ewing sarcoma.
Yuan B; Ji W; Xia H; Li J
Mol Med Rep; 2018 Mar; 17(3):4291-4298. PubMed ID: 29328472
[TBL] [Abstract][Full Text] [Related]
28. Identification of Common Oncogenic Genes and Pathways Both in Osteosarcoma and Ewing's Sarcoma Using Bioinformatics Analysis.
Zhang J; Huang J; Liu W; Ding L; Cheng D; Xiao H
J Immunol Res; 2022; 2022():3655908. PubMed ID: 35578666
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatics analysis of Ewing's sarcoma: Seeking key candidate genes and pathways.
Zhang J; Zhang Y; Li Z; Wu H; Xun J; Feng H
Oncol Lett; 2019 Dec; 18(6):6008-6016. PubMed ID: 31788075
[TBL] [Abstract][Full Text] [Related]
30. Ewing's sarcoma masquerading as an odontogenic infection.
Hamid R; Gaur A; Gupta S; Garg R
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S950-S953. PubMed ID: 38384088
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
Int J Oncol; 2016 Apr; 48(4):1531-40. PubMed ID: 26846737
[TBL] [Abstract][Full Text] [Related]
32. High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition.
Awad O; Yustein JT; Shah P; Gul N; Katuri V; O'Neill A; Kong Y; Brown ML; Toretsky JA; Loeb DM
PLoS One; 2010 Nov; 5(11):e13943. PubMed ID: 21085683
[TBL] [Abstract][Full Text] [Related]
33. Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1.
Oyama R; Kito F; Qiao Z; Sakumoto M; Noguchi R; Takahashi M; Toki S; Tanzawa Y; Yoshida A; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 Dec; 54(10):770-778. PubMed ID: 30324244
[TBL] [Abstract][Full Text] [Related]
34. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro.
Aryee DN; Niedan S; Kauer M; Schwentner R; Bennani-Baiti IM; Ban J; Muehlbacher K; Kreppel M; Walker RL; Meltzer P; Poremba C; Kofler R; Kovar H
Cancer Res; 2010 May; 70(10):4015-23. PubMed ID: 20442286
[TBL] [Abstract][Full Text] [Related]
36. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB
Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699
[TBL] [Abstract][Full Text] [Related]
37. PROGNOSTIC IMPLICATIONS OF PD-L1 EXPRESSION AND LOSS OF PTEN IN PATIENTS WITH RHABDOMYOSARCOMA, EWING'S SARCOMA AND OSTEOSARCOMA.
Abd Elmoneim HM; Huwait HF; Nafady-Hego H; Mohamed FA
Exp Oncol; 2023 Dec; 45(3):337-350. PubMed ID: 38186021
[TBL] [Abstract][Full Text] [Related]
38. Junction region of EWS-FLI1 fusion protein has a dominant negative effect in Ewing's sarcoma in vitro.
Jully B; Vijayalakshmi R; Gopal G; Sabitha K; Rajkumar T
BMC Cancer; 2012 Nov; 12():513. PubMed ID: 23145994
[TBL] [Abstract][Full Text] [Related]
39. Prediction of high risk Ewing's sarcoma by gene expression profiling.
Ohali A; Avigad S; Zaizov R; Ophir R; Horn-Saban S; Cohen IJ; Meller I; Kollender Y; Issakov J; Yaniv I
Oncogene; 2004 Nov; 23(55):8997-9006. PubMed ID: 15467746
[TBL] [Abstract][Full Text] [Related]
40. Ewing's sarcoma of bone. Experience with 140 patients.
Wilkins RM; Pritchard DJ; Burgert EO; Unni KK
Cancer; 1986 Dec; 58(11):2551-5. PubMed ID: 3768846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
